On or around 10/23/2018 (Notice of voluntarily dismissal)
Filing Date: October 11, 2018
According to the Complaint, K2M Group Holdings, Inc. ("K2M" or the Company) develops, commercializes, and manufactures complex spine and minimally invasive spine technologies and techniques used by spine surgeons globally.
On August 30, 2018, the Company announced the Proposed Transaction, the proposed acquisition of K2M by Stryker Corporation, in a press release. The Complaint alleges that on October 5, 2018, in order to convince K2M shareholders to vote in favor of the Proposed Transaction, the Board authorized the filing of a materially incomplete and misleading Proxy Statement on Schedule 14A (the “Proxy”) with the Securities and Exchange Commission (“SEC”), in violation of Sections 14(a) and 20(a) of the Exchange Act.
This case was voluntarily dismissed on October 23, 2018.
Company & Securities Information
Defendant: K2M Group Holdings, Inc.
Industry: Medical Equipment & Supplies
Headquarters: United States
Ticker Symbol: KTWO
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Charles Brown, et al. v. K2M Group Holdings, Inc., et al.